TOKYO STOCK EXCHANGE-TOKYO PRO MARKET · TAK
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Takeda Pharmaceutical Co Ltd

Takeda Pharmaceutical Co Ltd

Pharmaceuticals
$16.77

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is TAK moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Takeda Pharmaceutical Co Ltd
Pharmaceuticals
Listed since
2008
Employees
47K
Country
JP

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$16.77
Last session
Day high
$16.77
Last session
Day low
$16.77
Last session
Previous close
$16.77
52W high
$16.77
0.00% from high
52W low
$16.77
Market cap
$53B
P/E
43.60×
EPS
$122.17
Shares out
3.2B
VWAP
$16.77
Last session
Veridion warehouse edge

Warehouse intelligence for TAK.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

TAK insider activity

Takeda Pharmaceutical Co Ltd

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for TAK.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

TAK contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for TAK in this window.
Lobbying spend

TAK lobbying filings, year to date.

Registered lobbying filings matched to Takeda Pharmaceutical Co Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for TAK in this window.
Latest news · TAK
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for TAK.
Options
Sovereign unlock shows live options positioning for TAK.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.